ATTR Amyloidosis meeting 2025, Baveno, Italy
The ATTR Amyloidosis Congress 2025 held in Baveno, Italy, marked a pivotal moment for the global amyloidosis community.
With over 500 participants from across the globe, the event gathered researchers, healthcare professionals, patients, and industry partners under one roof to exchange the latest findings and strengthen collaboration.
For three days, the charming lakeside town became a hub of discussion, innovation, and shared determination to advance amyloidosis research.
A Celebration of Progress and Partnership
Throughout the congress, experts presented breakthrough findings on ATTR amyloidosis diagnosis, management, and therapy. From innovative imaging tools to emerging drug trials, the sessions reflected how much progress the field has achieved in recent years.
Beyond the scientific program, participants also engaged in networking sessions designed to foster stronger connections between medical teams, patient associations, and research networks.
The Amyloidosis Alliance played an active role in several panels, highlighting its mission to unify the voices of patients worldwide and accelerate access to quality care.
Our Gratitude to Partners and Sponsors
The Amyloidosis Alliance warmly thanks all the event partners, sponsors, and volunteers who made this exceptional gathering possible.
Their continuous support ensures that such international collaboration remains a reality and that amyloidosis continues to gain visibility within the broader medical community.
We believe that these connections and shared knowledge will pave the way for even faster progress in years to come.
Watch the Highlights
To relive the congress and feel the energy of our community, watch the official video summary. Together, we move forward with renewed hope and unity toward a brighter future for all affected by amyloidosis.